Literature DB >> 9221271

Vascular remodeling and mineralocorticoids.

K T Weber1, Y Sun, S E Campbell, S H Slight, V K Ganjam.   

Abstract

Circulating mineralocorticoid hormones are so named because of their important homeostatic properties that regulate salt and water balance via their action on epithelial cells. A broader range of functions in nonclassic target cellular sites has been proposed for these steroids and includes their contribution to wound healing following injury. A chronic, inappropriate (relative to intravascular volume and dietary sodium intake) elevation of these circulating hormones evokes a wound healing response in the absence of tissue injury--a wound healing response gone awry. The adverse remodeling of vascularized tissues seen in association with chronic mineralocorticoid excess is the focus of this review.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9221271     DOI: 10.1007/BF03349764

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  58 in total

1.  SELECTIVE HYPOALDOSTERONISM AFTER PROLONGED HEPARIN ADMINISTRATION. A CASE REPORT, WITH POSTMORTEM FINDINGS.

Authors:  I D WILSON; F C GOETZ
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  The general adaptation syndrome and the diseases of adaptation.

Authors:  H SELYE
Journal:  J Clin Endocrinol Metab       Date:  1946-02       Impact factor: 5.958

3.  Cardiac glucocorticoid receptors: the binding of tritiated dexamethasone in rat and dog heart.

Authors:  J W Funder; D Duval; P Meyer
Journal:  Endocrinology       Date:  1973-12       Impact factor: 4.736

4.  A case of polyarteritis developing after carbenoxolone therapy.

Authors:  J Sloan; J A Weaver
Journal:  Ir J Med Sci       Date:  1968-11       Impact factor: 1.568

5.  The effect of heparin on sodium conservation and on the plasma concentration, the metabolic clearance and the secretion and excretion rates of aldosterone in normal subjects.

Authors:  R E Bailey; H C Ford
Journal:  Acta Endocrinol (Copenh)       Date:  1969-02

6.  Growth factor expression in aorta of normotensive and hypertensive rats.

Authors:  R Sarzani; P Brecher; A V Chobanian
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.

Authors:  Y Sun; A Ratajska; G Zhou; K T Weber
Journal:  J Lab Clin Med       Date:  1993-10

8.  Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.

Authors:  C G Brilla; L S Matsubara; K T Weber
Journal:  J Mol Cell Cardiol       Date:  1993-05       Impact factor: 5.000

9.  Species diversity of 11 beta-hydroxysteroid dehydrogenase in the cardiovascular system.

Authors:  S Slight; V K Ganjam; K T Weber
Journal:  J Lab Clin Med       Date:  1994-12

10.  Peripheral serum corticosteroid concentrations in relation to the rat adrenal cortical circadian rhythm in androgen-induced hypertension.

Authors:  C S Fink; S Gallant; A C Brownie
Journal:  Hypertension       Date:  1980 Sep-Oct       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.